Royalty Pharma urges U.S. court to let Elan bid proceed
June 09, 2013 at 16:15 PM EDT
NEW YORK, June 9 (Reuters) - Investment partnership Royalty Pharma on Sunday urged a federal court in New York to allow it to proceed with a potential $8 billion bid for Irish drug company Elan Corp.
